Vivos (RDGL) EPS (Basic) Growth (1y) (2011 - 2025)
Vivos (RDGL) EPS (Basic) Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn | -18.87% |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn | 13.56% |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn | 97.93% |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | 92.23% |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn | -29.95% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn | 114.97% |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 | 4.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.62% |
| Sep 30, 2025 | 43.36% |
| Jun 30, 2025 | -14.04% |
| Mar 31, 2025 | -29.83% |
| Dec 31, 2024 | 14.41% |
| Sep 30, 2024 | -9.40% |
| Jun 30, 2024 | 49.09% |
| Mar 31, 2024 | -109.41% |
| Dec 31, 2023 | -45.33% |
| Sep 30, 2023 | -133.32% |
| Jun 30, 2023 | -7.05% |
| Mar 31, 2023 | 66.37% |
| Dec 31, 2022 | -267.11% |
| Sep 30, 2022 | -28.81% |
| Jun 30, 2022 | 59.60% |
| Mar 31, 2022 | -112.42% |
| Dec 31, 2021 | 59.66% |
| Sep 30, 2021 | -3.66% |
| Jun 30, 2021 | -517.02% |
| Mar 31, 2021 | 49.66% |